Teva Pharmaceuticals Generics and Innovative Medicines

Teva Pharmaceutical Industries Ltd. is a global leader in the pharmaceutical industry, renowned primarily as the world's largest manufacturer of generic medicines. Founded in Jerusalem in 1901, the company has evolved from a small local distributor into a multinational powerhouse with a diverse portfolio that includes both generic and innovative specialty treatments. Their product range spans various therapeutic areas such as neuroscience, oncology, and respiratory health.

The brand's footprint is truly global, with manufacturing facilities located across Europe, North America, Asia, and Israel. This extensive supply chain network allows Teva to provide essential medications to millions of patients daily. By leveraging high-volume production and a robust research and development pipeline, they focus on increasing the accessibility and affordability of healthcare worldwide.

Ownership of the brand remains with the parent entity, Teva Pharmaceutical Industries Ltd., which is headquartered in Tel Aviv, Israel. As an independent, publicly-traded company, it operates numerous local subsidiaries to manage regional distribution and compliance. The brand continues to pivot toward a 'growth' strategy, emphasizing the development of biosimilars and innovative biologics alongside its core generics business to address unmet medical needs.